Introducing RushMab® – Gene, 100ug transfection-grade expression plasmids ready in 4 DAYS!

Jul 16, 2024

Posted by Biointron Biological

Biointron’s Q2 2024 Antibody Industry Report is OUT NOW!

Jul 16, 2024

Posted by Biointron Biological

Upperton Pharma Solutions Adds Large-Scale Processing Following MHRA Approval at Nottingham Facility.

Jul 15, 2024

Posted by Upperton

RENTSCHLER BIOPHARMA ANNOUNCES NEW STATE-OF-THE-ART PRODUCTION LINE IN MASSACHUSETTS IS FULLY OPERATIONAL!

Jul 11, 2024

Posted by Rentschler Biopharma Inc

Allucent Awarded 5-Year BARDA Agreement Aimed at Enhancing and Accelerating Decentralized Clinical Trials for Medical Countermeasure Development

Jul 11, 2024

Posted by Allucent

Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipalertinib

Jul 10, 2024

Posted by Cullinan Therapeutics

Philadelphia Business Journal Features AscellaHealth CFO Mario Patone in Corporate Leadership Awards

Jul 09, 2024